Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Allison T. Vidimos, RPh, MD, is Chairman of the Department of Dermatology, and Staff Physician in the Section of Micrographic Surgery (Mohs) and Oncology in the Department of Dermatology, and Professor, CCLCM. She is also the Program Director of the Procedural DermatologyFellowship.
Dr. Vidimos received a Bachelor of Science degree in Pharmacy with distinction from Purdue University in West Lafayette, Ind., and she received a medical degree with highest distinction from Indiana University School of Medicine in Indianapolis. Dr. Vidimos completed a medical internship and residency in dermatology at Cleveland Clinic, followed by a fellowship in Mohs Surgery. Dr. Vidimos is a Diplomate of the National Board of Medical Examiners and the American Board of Dermatology.
Her special interests include skin cancer, Mohs surgery, and laser surgery.
Dr. Vidimos has been chosen one of the “Best Doctors in America” every year since 1998. She is currently a member of the Board of Directors of the American College of Mohs Surgery, the Scientific Assembly Committee for the American Academy of Dermatology, and the editorial board of the Journal of the American Academy of Dermatology. Dr. Vidimos has lectured extensively and has written numerous journal articles, book chapters, and two textbooks.
Mohs micrographic surgery, cutaneous oncology, laser surgery Cutaneous oncology, laser surgery, mohs micrographic surgery, vascular anomalies
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 1/19/2014, Dr. Vidimos has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Charity. Dr. Vidimos has consulted for the following companies but instructed them to donate all compensation directly to one or more non-profit organizations:
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.